Yuntu Holdings: 3655700 shares in the repurchase account have been transferred to the special account for the third phase of employee stock ownership plan

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.

Ningbo Ocean Shipping Launches First Europe-Bound Ro-Ro Service

On August 5, 2026, Ningbo Ocean Shipping Co., Ltd. (宁波远洋运输股份有限公司) launched its first roll-on/roll-off shipping service to Europe from Ningbo Zhoushan Port, marking the company’s entry into vehicle transportation and the first extension of its route network to the European continent.

JMEV Overseas Sales Rise 99% in First Half as Right-Hand-Drive Expansion Gains Pace

JMEV（江铃集团新能源）said its overseas sales rose 99% year on year in the first half of 2026, as the Chinese electric-vehicle maker added four export markets, including Brunei and Peru, and rolled out more right-hand-drive products.